Allotex
Boston
About Allotex
Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $30.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2023)
- Website: allotex.com
- Phone: 617-391-9544
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/allotex-117524 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.